These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10789070)

  • 1. Enhancing effects of fatty acids on piroxicam permeation through rat skins.
    Shin SC; Shin EY; Cho CW
    Drug Dev Ind Pharm; 2000 May; 26(5):563-6. PubMed ID: 10789070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of non-ionic surfactants as permeation enhancers towards piroxicam from the poloxamer gel through rat skins.
    Shin SC; Cho CW; Oh IJ
    Int J Pharm; 2001 Jul; 222(2):199-203. PubMed ID: 11427350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Permeation of piroxicam from the poloxamer gels.
    Shin SC; Cho CW; Choi HK
    Drug Dev Ind Pharm; 1999 Mar; 25(3):273-8. PubMed ID: 10071819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced efficacy by percutaneous absorption of piroxicam from the poloxamer gel in rats.
    Shin S; Cho C; Oh I
    Int J Pharm; 2000 Jan; 193(2):213-8. PubMed ID: 10606784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of skin pretreatment with fatty acids on percutaneous absorption and skin retention of piroxicam after its topical application.
    Santoyo S; Ygartua P
    Eur J Pharm Biopharm; 2000 Sep; 50(2):245-50. PubMed ID: 10962234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced transdermal delivery of ketoprofen from bioadhesive gels.
    Singh S; Gajra B; Rawat M; Muthu MS
    Pak J Pharm Sci; 2009 Apr; 22(2):193-8. PubMed ID: 19339232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Ultrasound Intensity and Mode on Piroxicam Transport Across Three-Dimensional Skin Equivalent Epiderm™.
    Alarjah MA
    Recent Pat Drug Deliv Formul; 2020; 14(1):75-83. PubMed ID: 32106808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transdermal lontophoresis and skin retention of piroxicam from gels containing piroxicam: hydroxypropyl-beta-cyclodextrin complexes.
    Doliwa A; Santoyo S; Ygartua P
    Drug Dev Ind Pharm; 2001 Sep; 27(8):751-8. PubMed ID: 11699826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transdermal delivery of piroxicam using microemulsions.
    Park ES; Cui Y; Yun BJ; Ko IJ; Chi SC
    Arch Pharm Res; 2005 Feb; 28(2):243-8. PubMed ID: 15789759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transbuccal permeation, anti-inflammatory activity and clinical efficacy of piroxicam formulated in different gels.
    Attia MA; El-Gibaly I; Shaltout SE; Fetih GN
    Int J Pharm; 2004 May; 276(1-2):11-28. PubMed ID: 15113610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of vehicles and penetration enhancers on the in vitro percutaneous absorption of tenoxicam through hairless mouse skin.
    Gwak HS; Chun IK
    Int J Pharm; 2002 Apr; 236(1-2):57-64. PubMed ID: 11891070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ex vivo Skin Permeation Evaluation of An Innovative Transdermal Vehicle Using Nimesulide and Piroxicam as Model Drugs.
    Pereira RO; Pelisson E Silva TCC; de Oliveira Ferreira A; Brandao MAF; Raposo NRB; Polonini HC
    Curr Drug Deliv; 2017; 14(4):516-520. PubMed ID: 27557671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rheological characterization and in vivo evaluation of thermosensitive poloxamer-based hydrogel for intramuscular injection of piroxicam.
    Xuan JJ; Balakrishnan P; Oh DH; Yeo WH; Park SM; Yong CS; Choi HG
    Int J Pharm; 2010 Aug; 395(1-2):317-23. PubMed ID: 20573569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancing effects of unsaturated fatty acids with various structures on the permeation of indomethacin through rat skin.
    Morimoto K; Tojima H; Haruta T; Suzuki M; Kakemi M
    J Pharm Pharmacol; 1996 Nov; 48(11):1133-7. PubMed ID: 8961160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined effect of oleic acid and propylene glycol on the percutaneous penetration of tenoxicam and its retention in the skin.
    Larrucea E; Arellano A; Santoyo S; Ygartua P
    Eur J Pharm Biopharm; 2001 Sep; 52(2):113-9. PubMed ID: 11522475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and biopharmaceutical evaluation of quinupramine-EVA matrix containing penetration enhancer for the enhanced transdermal absorption in rats.
    Shin SC; Kim J; Kim WJ; Kim SJ; Cho CW
    Pharm Dev Technol; 2007; 12(5):429-36. PubMed ID: 17963142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced transdermal delivery of pranoprofen from the bioadhesive gels.
    Shin SC; Cho CW
    Arch Pharm Res; 2006 Oct; 29(10):928-33. PubMed ID: 17121190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of diethylene glycol monoethyl ether on skin penetration ability of diclofenac acid nanosuspensions.
    Pireddu R; Sinico C; Ennas G; Schlich M; Valenti D; Murgia S; Marongiu F; Fadda AM; Lai F
    Colloids Surf B Biointerfaces; 2018 Feb; 162():8-15. PubMed ID: 29132043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of the ambroxol gels for enhanced transdermal delivery.
    Cho CW; Choi JS; Shin SC
    Drug Dev Ind Pharm; 2008 Mar; 34(3):330-5. PubMed ID: 18363149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitive LC determination of piroxicam after in vitro transdermal permeation studies.
    Doliwa A; Santoyo S; Campanero MA; Ygartua P
    J Pharm Biomed Anal; 2001 Nov; 26(4):531-7. PubMed ID: 11516903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.